Sean Lavin, MD, Joins Progenity as Vice President, Business Development, Strategy, and Investor Relations
SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the appointment […]